Literature DB >> 6487492

Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

S C Mitchell, R H Waring, C S Haley, J R Idle, R L Smith.   

Abstract

Interindividual variation in the sulphoxidation of S-carboxymethyl-L-cysteine (750 mg p.o.) was investigated in 200 healthy volunteers. Nearly a 100-fold difference was observed between individuals with respect to the amount of sulphoxide metabolites detected in their 0-8 h urine (0.6 to 59.1% recovery). Such a difference was shown to be reproducible over several months in 40 subjects who spanned the entire range of capacities. Cumulative plots and maximum likelihood analysis of the distribution indicated that a bimodal model was most probable. Analysis of pedigree data obtained from 12 families suggested a genetic effect with overlying environmental influences.

Entities:  

Keywords:  Behavior; Biology; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Diseases; Drugs; Family Planning; Genetics; Metabolic Effects; Oral Contraceptives--side effects; Physiology; Smoking; Social Behavior; Treatment

Mesh:

Substances:

Year:  1984        PMID: 6487492      PMCID: PMC1463607          DOI: 10.1111/j.1365-2125.1984.tb02498.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  28 in total

1.  Skewness in commingled distributions.

Authors:  C J Maclean; N E Morton; R C Elston; S Yee
Journal:  Biometrics       Date:  1976-09       Impact factor: 2.571

2.  Assay procedures for thioridazine, trifluoperazine, and their sulfoxides and determination of urinary excretion of these compounds in mental patients.

Authors:  N R West; M P Rosenblum; H Sprince; S Gold; D H Boehme; W H Vogel
Journal:  J Pharm Sci       Date:  1974-03       Impact factor: 3.534

3.  Variations in levels of blood clotting factors IX and X in a population of normal men: possible genetic polymorphisms.

Authors:  R H Lester; R C Elston; J B Graham
Journal:  Am J Hum Genet       Date:  1972-03       Impact factor: 11.025

4.  Impairment of human drug metabolism by oral contraceptive steroids.

Authors:  K O'Malley; I H Stevenson; J Crooks
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

5.  The acetylation of S-alkylcysteines by the rat.

Authors:  E A Barnsley; N A Eskin; S P James; R H Waring
Journal:  Biochem Pharmacol       Date:  1969-10       Impact factor: 5.858

6.  [Resorption, excretion and biotransformation in dogs and rabbits, biotransformation in man of (methyl-10 phenothiazinyl-2) acetic acid (methiazinic acid--16091 R. P)].

Authors:  P Populaire; B Terlain; S Pascal; G Lebreton; B Decouvelaere
Journal:  Arzneimittelforschung       Date:  1969-08

7.  Formation of mercapturic acids. 5. Metabolism of some halogenoparaffins and nitroparaffins.

Authors:  H G Bray; J C Caygill; S P James; P B Wood
Journal:  Biochem J       Date:  1964-01       Impact factor: 3.857

8.  Biochemical studies of toxic agents. 15. The biosynthesis of ethylmercapturic acid sulphoxide.

Authors:  E A Barnsley; A E Thomson; L Young
Journal:  Biochem J       Date:  1964-03       Impact factor: 3.857

9.  Testing of single locus hypotheses where there is incomplete separation of the phenotypes.

Authors:  E A Murphy; D R Bolling
Journal:  Am J Hum Genet       Date:  1967-05       Impact factor: 11.025

10.  The metabolism of S-methyl-L-cysteine.

Authors:  N M Sklan; E A Barnsley
Journal:  Biochem J       Date:  1968-03       Impact factor: 3.857

View more
  16 in total

Review 1.  Inborn 'errors' of drug metabolism. Pharmacokinetic and clinical implications.

Authors:  M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

2.  Increased prevalence of poor sulphoxidation in patients with rheumatoid arthritis: effect of changes in the acute phase response and second line drug treatment.

Authors:  P Emery; H Bradley; A Gough; V Arthur; R Jubb; R Waring
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

3.  Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.

Authors:  J Brockmöller; B Staffeldt; I Roots
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

5.  Curiosity.

Authors:  C M Harris
Journal:  J R Soc Med       Date:  1986-06       Impact factor: 5.344

6.  Odorous urine following asparagus ingestion in man.

Authors:  S C Mitchell; R H Waring; D Land; W V Thorpe
Journal:  Experientia       Date:  1987-04-15

Review 7.  The aetiology of idiopathic Parkinson's disease.

Authors:  D B Ramsden; R B Parsons; S L Ho; R H Waring
Journal:  Mol Pathol       Date:  2001-12

Review 8.  Genetically determined adverse drug reactions involving metabolism.

Authors:  M S Lennard
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

9.  GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis.

Authors:  M H Davies; E Elias; S Acharya; W Cotton; G C Faulder; A A Fryer; R C Strange
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

Review 10.  Genetic variation in the human hepatic cytochrome P-450 system.

Authors:  W Kalow
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.